Video & Transcript : 'FDA user fees' :

Page 6 of 500
NM

New Mexico 2026 Regular Session

House - Health and Human Services Feb 6th, 2026 at 08:33 am

House Health & Human Services

Transcript Highlights:
  • Livanova, the manufacturer of the vagal nerve simulator, as approved by the FDA.
  • According to the Medicaid fee schedule, the effective date was January 1, 2015.
  • And until those are FDA approved, they're considered an off-label use, as you know.
  • In our FIR, it says that they are reimbursed at 100% of the Medicare fee schedule.
  • Actually, Representative, we are paying 150% of the Medicare fee schedule.
NM

New Mexico 2026 Regular Session

Senate - Finance Jan 21st, 2026 at 02:04 pm

Senate Finance

Transcript Highlights:
  • We also have an increase in taxes and fees to support the state. Road Fund.
  • The surcharge is additional to the registration fees. Thank you for your time, Madam.
  • How are we stacking up now with our neighboring states in terms of fees?
  • There's no additional fee today. You got to tell her what the question is, I don't know.
  • They have the bill we give them; we share with them the vehicle registration fees.
Bills: SB2 , SB2
WA
Transcript Highlights:
  • In 2022, the federal FDA Modernization Act 2.0...
  • We've seen additional fees that are added in.
  • We've seen additional fees that are added in.
  • Congress now considers the FDA Modernization Act 3.0, which would require the FDA Commissioner to actually
  • implement the FDA Modernization Act 2.0 with a final rule.
Summary: The committee held public hearings on several bills. House Bill 2542 would require drug developers to use validated non-animal testing methods when available, unless federal regulators request animal testing. The sponsor said the bill builds on prior Washington action on cosmetics testing and is intended to move toward more humane and modern science. Supporters, including students, animal welfare advocates, and biotech-related witnesses, argued that animal tests often fail to predict human outcomes and that alternatives are more accurate. A biotech industry representative said animal testing is still necessary for some research and warned the bill could deter local innovation, but said the industry was open to amendments. The sponsor said she was open to discussing changes to the enforcement mechanism. No vote was taken on the bill during the hearing. House Bill 2629 would address theft and vandalism of critical communications infrastructure, including copper and fiber lines. The bill would ban cash payments for nonferrous metal transactions, require electronic or stored-value payment methods, impose civil penalties for stolen copper used in telecommunications cable, and create a new Class C felony for destruction of critical communications infrastructure. The sponsor and industry witnesses described repeated outages affecting 911, hospitals, schools, and first responders, and said Washington has a high rate of these incidents. Recycling industry representatives supported the bill after negotiations, but a prosecutor and some others said the bill should focus more on law enforcement tools such as searchable transaction databases and holding periods rather than new penalties. No final action was taken in the hearing. House Bill 2394 would expand the Insurance Commissioner’s insurance fraud program and create a Class B felony for insurance fraud, including fraudulent billing, misrepresentation of repair costs, and misuse of coding systems. The bill also broadens who can be considered a victim for restitution and gives the commissioner additional investigative tools, while the substitute removed a reporting duty for certified public accountants. The sponsor and the Insurance Commissioner’s office said the measure responds to more sophisticated, technology-driven fraud schemes that harm both insurers and consumers. Insurance industry and fraud bureau witnesses supported the bill as a consumer protection measure. No vote was taken. House Bill 2361 would raise the maximum principal amount for small loans from $700 to $1,200, with annual inflation adjustments, while keeping the existing 30% of monthly income cap and other safeguards. The sponsor said the change would better reflect emergency costs and help borrowers avoid illegal lenders. DFI raised implementation questions about inflation adjustments and publication requirements, and opponents from AARP, SEIU 775, poverty advocates, and consumer attorneys argued the bill would increase debt traps and fees for low-income borrowers and older adults. MoneyTree supported the bill, saying the current cap is outdated and that the product remains a flat-fee, regulated credit option with existing consumer protections. The hearing also included testimony on House Bill 2294, which would prohibit negative use restrictions on real property that block grocery stores or pharmacies; staff described a proposed amendment adding notice and changing enforcement, and the committee then moved the bill out with a due pass recommendation.
WA

Washington 2025-2026 Regular Session

Senate Ways & Means Jan 22nd, 2026

Transcript Highlights:
  • The current language creates some burdensome compliance and PII concerns for our users, so our hope is
  • DOR has already had the information of any users who receive the reseller permit or an exemption.
  • Higher prices deter young people from starting and provide a powerful incentive for current users to
  • The FDA says we're on the continual to fix the tax problem. It's important until November 25th.
  • for purposes of the fee.
Summary: The committee held a public hearing on several tax and retirement bills, beginning with Senate Bill 6073, which would move eligible Department of Natural Resources wildland and aviation firefighters from PERS into LEOFF 2 prospectively. Committee staff described the higher retirement age and benefit differences between the systems and noted a small implementation cost and a modest actuarial rate increase. DNR, the Washington Public Employees Association, and a committee member all raised support or questions, with DNR acknowledging additional review with the LEOFF board was still needed. The hearing then turned to Senate Bill 6113, a Department of Revenue request bill making technical and administrative changes to the tax code, including clarifications tied to last session’s ESSB 5814 service-tax changes, a six-month transition period for reclassified businesses, and a section affecting advertising-related exclusions. DOR said the bill was revenue neutral and intended to codify guidance and improve certainty, while school districts, arts groups, broadcasters, newspapers, and business groups testified both in support of the technical fixes and in opposition to provisions they said would continue or worsen unintended consequences from last year’s tax law. Senators also questioned how some definitions would apply, especially to school and higher-education-related services. Senate Bill 6116 would restore the vapor-products tax structure by moving nicotine-containing vapor products back under the per-milliliter vapor tax instead of the 95% other tobacco products tax, and would restore distributions to the Andy Hill Cancer Research account and Foundational Public Health Services account. Public health agencies, cancer research representatives, and some retailers supported the bill as a fix to funding disruptions, while tobacco-control groups opposed lowering the tax and argued it would weaken public health policy. The committee also heard that the current law creates a double-tax issue on pre-existing inventory because products held when the definition changed became subject to a new tax classification. Finally, Senate Bill 6129 proposed a broader nicotine-tax overhaul, including a 90% tax on nicotine products, a 10% tax on flavored nicotine products, higher cigarette taxes, and new revenue distributions and tribal compact provisions. Supporters, including public health organizations, pediatricians, and civil rights advocates, said higher taxes would reduce youth use and restore funding for cancer research and public health; opponents, including retailers, tobacco and vapor businesses, broadcasters, and some harm-reduction advocates, argued the bill was regressive, would fuel illicit markets, and would harm small businesses and adult consumers using lower-risk products. The committee then began a briefing on Senate Bill 6162, a property tax reform bill that would expand senior and disability property tax relief, adjust state property tax rates, and change property tax billing statements, but the hearing on that bill was not completed in the portion provided.
OK
Transcript Highlights:
  • Members, since 2009, when the fee structure for the Construction Industries Board, the fee structures
  • Construction Industries Board has presented a fair and responsible assessment that we adjust their fee
  • be a barrier for people to be able to even get into the trades due to the large increase of these fees
  • I don't believe I would say that, thinking through the fee structure that they've asked for.
  • That they didn't ask for any fees that I would consider absorbitant.
Bills: SB1239 , SB1732
WA

Washington 2025-2026 Regular Session

House Transportation Feb 2nd, 2026 at 04:00 pm

Transportation

Transcript Highlights:
  • House Bill 2601 is about motorcycle weight fees.
  • Currently, motorcycles pay a weight fee of $35 at registration because that is the fee for the lowest
  • , not based on their weight, with a fee of $15.
  • This lower fee would take effect in July of 2007.
  • In the vehicle weight fee schedule, House Bill 2601 would create a new lower category in the weight fee
Bills: HB2305 , HB2601 , HB2604
LA

Louisiana 2026 Regular Session

Health and Welfare May 6th, 2026

Health and Welfare

Transcript Highlights:
  • This is a bill about providing prices for hospital events and fees online, hospital transparency.
  • This is a bill about providing prices for hospital events and fees online, hospital transparency.
Bills: SB57 , SB405 , HB62 , HB193 , HB203 , HB222 , HB246 , HB420 , HB475 , HB486 , HB574 , HB584 , HB815 , HB949 , HB1092 , HB1214
TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Apr 17th, 2025

S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • The FDA does not regulate what a physician... ...a physician can prescribe a medication for.
  • The FDA regulates—Chair recognizes Representative Cunningham as present.
  • The FDA regulates what the manufacturer of that drug can market it to providers for.
  • .. ...one that I was on previously changed and decided, "Well, we're just going to go with what the FDA
  • Now, of course, the FDA has ruled that you can't use certain private sources to get medications anymore
AZ

Arizona 2026 Regular Session

02/04/2026 - House Judiciary

House Judiciary Committee of Reference

Transcript Highlights:
  • There are other fees that this bill addresses, like the right to a fee for appeal, and in my view, we
  • In Arizona, however, there is a fee for some of these and the ability to charge a fee for others.
  • This bill However, there is a fee for some of these and the ability to charge a fee for others.
  • This bill removes that fee and blocks future fees on any constitutional rights that we have.
  • collection of the fees.
Summary: The committee first heard HB 2415, which would regulate kratom by treating certain synthetically derived compounds as narcotic drugs, raising the minimum sale age to 21, and penalizing sales of products exceeding a 400 parts per million cap. The sponsor and supporters argued the bill targets dangerous synthetic or highly concentrated kratom while preserving natural leaf products; testimony included a woman describing kratom addiction and treatment, family members describing harm from 7-OH products, and law enforcement and Attorney General’s Office support. Opponents, including criminal justice advocates, warned the bill could sweep in users and create harsh felony penalties, while some speakers urged a full ban and others defended natural kratom as distinct from synthetic products. The committee adopted the Wynn amendment and then gave HB 2415, as amended, a do-pass recommendation by a 6-3 vote. The committee then considered HB 2870, which would prohibit more than one Level 2 or Level 3 registered sex offender from residing in the same home unless they are related by blood, marriage, or adoption. The sponsor said the bill was prompted by a neighborhood case involving multiple sex offenders in one residence and argued it was aimed at residential homes, not supervised group homes. Supporters described fear and disruption in their neighborhoods, while opponents argued the bill would reduce already limited housing, make supervision harder, and potentially force people onto the streets; some also raised due process and recidivism concerns. After discussion about possible amendments and the distinction between group homes and unsupervised residences, the committee approved HB 2870 with a do-pass recommendation by a 6-3 vote. Next, the committee heard HB 2413, which requires GPS or electronic monitoring for registered sex offenders who are homeless or lack a permanent address until they obtain one. Supporters said the bill would close a gap because transient registrants are only required to check in every 90 days, leaving law enforcement without regular location information; a policy analyst said monitoring could be implemented through existing systems, though costs and administration would vary. Opponents argued the bill raises due process and equal protection concerns, duplicates existing reporting requirements, and could impose costs on people trying to stabilize their lives. The committee passed HB 2413 on a 5-4 vote. Finally, the committee took up HB 2720, which increases the penalty for purchasing prostitution to a class 6 felony and directs a $200 assessment to the anti-human trafficking fund, with an amendment clarifying the affirmative defense for trafficking victims and restricting use of the assessment to trafficking services. Supporters, including the sponsor, prosecutors, Phoenix police, and a city council member, said the bill targets buyers who drive demand and exploitation. Opponents from criminal justice and anti-violence groups argued the bill could still ensnare trafficking victims and sex workers, especially because the affirmative defense may be hard to assert in practice. After adopting the amendment, the committee gave HB 2720, as amended, a do-pass recommendation by an 8-0-1 vote.
CA

California 2025-2026 Regular Session

Assembly Business and Professions Committee Jan 13th, 2026

Business and Professions

Transcript Highlights:
  • They're not FDA-controlled.
  • They may have to pay a small fee, but there's no teeth to it.
  • It's my understanding that the glowfish, which are FDA approved, are exempted from the bill.
  • structure rather than an all-in management fee.
  • Some of those fees are paid by the HOA through a fee schedule that they've negotiated with the service
CA
Transcript Highlights:
  • They will continue to mislead consumers, and they contradict the FDA.
  • And the good news is that the FDA is starting to act.
  • And the good news is that the FDA is starting to act.
  • But FDA is starting to get serious, particularly about advertising.
  • And so the prices now are basically comparable for an FDA-approved, basically comparable for an FDA-approved
Summary: The Assembly Business and Professions Committee heard a long agenda of bills, with several cannabis-related measures drawing the most testimony. AB 1598 would extend and standardize licensing timelines for behavioral health professionals, AB 1850 would clarify that real estate wholesalers are subject to licensure and disclosure rules, AB 1794 would allow enteral formula to be shipped directly to patients’ homes, and AB 2402 would update an old cap on fees for multi-service health club studios. The committee also heard AB 1990 on compounded GLP-1 drugs, AB 2249 on cannabis packaging attractive to children, AB 2532 on cannabis beverage serving sizes, AB 2537 on prioritizing cannabis enforcement, and AB 1826 on due process protections for cannabis businesses facing embargoes or recalls. Testimony was generally split between public health or consumer-protection advocates and industry representatives. Supporters of the cannabis bills argued for clearer rules, better consumer safety, and more predictable enforcement, while opponents warned that some proposals could overreach, burden compliant businesses, or restrict legitimate branding and access. On AB 1990, supporters said compounded GLP-1 products need stronger testing and truthful advertising, while pharmacists and compounding advocates said existing law already covers much of the conduct and that the bill could create access problems. On AB 2249 and AB 2532, public health witnesses emphasized risks to children and accidental overconsumption, while industry groups sought narrower language and more implementation time. The committee took several roll-call votes after quorum was established. AB 2249, AB 1826, AB 2402, AB 1794, and AB 2532 were all approved and sent to Appropriations, and AB 1826 was sent to Judiciary. The chair and members repeatedly noted accepted committee amendments and, in several cases, said they were prepared to support the bills with those amendments. Some measures were left open or held pending further action as the hearing continued.
HI
Transcript Highlights:
  • Under the bill, how much do you expect to raise from the redirection of the vital records fee?
  • </c> rates low uh among conjection drug users rates low uh among conjection drug users and<00:47:54.319
  • </c> to include non- injection drug users to include non- injection drug users send<00:49:37.400><c>
  • </c><01:18:40.920><c> one</c><01:18:41.040><c> of</c><01:18:41.199><c> the</c> designation by the FDA
  • </c> of which have been designated by the FDA of which have been designated by the FDA is<01:19:54.880
Committee: House Health
Summary: The Committee on Health heard testimony on several bills. On SB 1441, which would repeal the transfer of the Oahu Regional Health Care System from HHSC to the Department of Health, the Department of Health said it strongly supports the measure and requested clarifying amendments. HHSC/Oahu Region also supported the bill and said it had no objection to the department’s amendments. In response to questions, witnesses said the agencies have been working on an MOU to support transfers of long-term care patients to Leahi, with the current goal being about 10 to 15 patients, but transfers would occur only as space and staffing allow; one patient was reportedly being admitted at the time, and the process was described as slow and case-by-case. The committee then heard SB 1443 on payment rates for state hospital patients and related Department of Health services. The hospital administrator said the bill would allow rates above Medicaid for community or foster-home placements if patients cannot be placed at Leahi or elsewhere, and would set Medicaid-level reimbursement for outside medical services used by state hospital patients. He said at least one provider was interested in offering services at that rate and that the population involved is largely non-ambulatory long-term care patients. Members asked about availability and training, and the witness said special training could be provided. SB 1322, a broad mental health bill, drew mixed testimony. The Department of Law Enforcement supported giving crisis-intervention-trained officers more discretion to transport people to medical care instead of arresting them. The Attorney General supported the bill but recommended revisions to emergency-transport language and restoring liability protections. HHSC and Queens Hospital supported the overall goal but sought amendments to preserve the mental health emergency worker role in decision-making and to avoid negative impacts on emergency departments. The Disability Rights Center and ACLU opposed parts of the bill, arguing that it weakens due process, reduces protections in involuntary treatment and transport, and should retain a three-person treatment panel rather than reduce it to one. A Queens representative said the current program works well and reported that more than 90% of MH1 cases once went to hospitals, but that figure has dropped to about 60-70%, with about 20% now diverted to community settings or the behavioral health crisis center. No votes or final committee actions were taken in the portion provided.
MN

Minnesota 2025-2026 Regular Session

House Capital Investment Committee 3/11/25

Capital Investment

Transcript Highlights:
  • Representative Igo: Can you incorporate development fees into your plats to cover the cost of this?
  • Mayor Tad Farrell: Yes, um, we can, but in northern Minnesota, when you start putting too many fees on
  • Mayor Tad Farrell: In the cities, you take a lot that costs $15,000, you start putting all these fees
  • </c><01:06:48.520><c> pretty</c><01:06:48.760><c> much</c> have been real water users pretty much have
  • </c><01:37:40.599><c> along</c> sites and accommodate ATV users along sites and accommodate ATV users
MN

Minnesota 2025-2026 Regular Session

Committee on Capital Investment - 03/11/25

Capital Investment

Transcript Highlights:
  • And so it's very user-friendly for cities to get into that process, and then it's just a matter of getting
  • And so it's very user-friendly for cities to get into that process, and then it's just a matter of getting
  • And so it's very user-friendly for cities to get into that process, and then it's just a matter of getting